156 related articles for article (PubMed ID: 29321004)
1. RCC2 over-expression in tumor cells alters apoptosis and drug sensitivity by regulating Rac1 activation.
Wu N; Ren D; Li S; Ma W; Hu S; Jin Y; Xiao S
BMC Cancer; 2018 Jan; 18(1):67. PubMed ID: 29321004
[TBL] [Abstract][Full Text] [Related]
2. RCC2, a regulator of the RalA signaling pathway, is identified as a novel therapeutic target in cisplatin-resistant ovarian cancer.
Gong S; Chen Y; Meng F; Zhang Y; Wu H; Li C; Zhang G
FASEB J; 2019 Apr; 33(4):5350-5365. PubMed ID: 30768358
[TBL] [Abstract][Full Text] [Related]
3. RCC2 is a novel p53 target in suppressing metastasis.
Song C; Liang L; Jin Y; Li Y; Liu Y; Guo L; Wu C; Yun CH; Yin Y
Oncogene; 2018 Jan; 37(1):8-17. PubMed ID: 28869598
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial-Mesenchymal Transition.
Pang B; Wu N; Guan R; Pang L; Li X; Li S; Tang L; Guo Y; Chen J; Sun D; Sun H; Dai J; Bai J; Ji G; Liu P; Liu A; Wang Q; Xiao S; Fu S; Jin Y
Clin Cancer Res; 2017 Sep; 23(18):5598-5610. PubMed ID: 28606921
[No Abstract] [Full Text] [Related]
5. Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6.
Humphries JD; Byron A; Bass MD; Craig SE; Pinney JW; Knight D; Humphries MJ
Sci Signal; 2009 Sep; 2(87):ra51. PubMed ID: 19738201
[TBL] [Abstract][Full Text] [Related]
6. RCC2 promotes proliferation and radio-resistance in glioblastoma via activating transcription of DNMT1.
Yu H; Zhang S; Ibrahim AN; Wang J; Deng Z; Wang M
Biochem Biophys Res Commun; 2019 Aug; 516(3):999-1006. PubMed ID: 31277942
[TBL] [Abstract][Full Text] [Related]
7. Regulator of Chromosome Condensation 2 Identifies High-Risk Patients within Both Major Phenotypes of Colorectal Cancer.
Bruun J; Kolberg M; Ahlquist TC; Røyrvik EC; Nome T; Leithe E; Lind GE; Merok MA; Rognum TO; Bjørkøy G; Johansen T; Lindblom A; Sun XF; Svindland A; Liestøl K; Nesbakken A; Skotheim RI; Lothe RA
Clin Cancer Res; 2015 Aug; 21(16):3759-70. PubMed ID: 25910952
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of RAC1-GEF DOCK3 by miR-512-3p contributes to suppression of metastasis in non-small cell lung cancer.
Zhu X; Gao G; Chu K; Yang X; Ren S; Li Y; Wu H; Huang Y; Zhou C
Int J Biochem Cell Biol; 2015 Apr; 61():103-14. PubMed ID: 25687035
[TBL] [Abstract][Full Text] [Related]
9. Coronin-1C and RCC2 guide mesenchymal migration by trafficking Rac1 and controlling GEF exposure.
Williamson RC; Cowell CA; Hammond CL; Bergen DJ; Roper JA; Feng Y; Rendall TC; Race PR; Bass MD
J Cell Sci; 2014 Oct; 127(Pt 19):4292-307. PubMed ID: 25074804
[TBL] [Abstract][Full Text] [Related]
10. MiR-29c is downregulated in gastric carcinomas and regulates cell proliferation by targeting RCC2.
Matsuo M; Nakada C; Tsukamoto Y; Noguchi T; Uchida T; Hijiya N; Matsuura K; Moriyama M
Mol Cancer; 2013 Feb; 12():15. PubMed ID: 23442884
[TBL] [Abstract][Full Text] [Related]
11. RCC2 promotes prostate cancer cell proliferation and migration through Hh/GLI1 signaling pathway and cancer stem-like cells.
Wang S; Lei Z; Liu W; Xiong J; Shi Y; Yang L; Gao Q; Le K; Zhang B
Biol Direct; 2023 Nov; 18(1):80. PubMed ID: 38008751
[TBL] [Abstract][Full Text] [Related]
12. [Significance of expression of T lymphoma invasion/metastasis gene in ovarian cancer cells].
Wu MF; Xi L; Chen G; Li J; Xu Q; Li FJ; Lu YP; Wang SX; Liao GN; Ma D
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):434-7. PubMed ID: 12974090
[TBL] [Abstract][Full Text] [Related]
13. Epigenetically altered miR-1247 functions as a tumor suppressor in pancreatic cancer.
Yi JM; Kang EJ; Kwon HM; Bae JH; Kang K; Ahuja N; Yang K
Oncotarget; 2017 Apr; 8(16):26600-26612. PubMed ID: 28460450
[TBL] [Abstract][Full Text] [Related]
14. RCC2 Promotes Esophageal Cancer Growth by Regulating Activity and Expression of the Sox2 Transcription Factor.
Calderon-Aparicio A; Yamamoto H; De Vitto H; Zhang T; Wang Q; Bode AM; Dong Z
Mol Cancer Res; 2020 Nov; 18(11):1660-1674. PubMed ID: 32801160
[TBL] [Abstract][Full Text] [Related]
15. Prohibitin silencing reverses stabilization of mitochondrial integrity and chemoresistance in ovarian cancer cells by increasing their sensitivity to apoptosis.
Gregory-Bass RC; Olatinwo M; Xu W; Matthews R; Stiles JK; Thomas K; Liu D; Tsang B; Thompson WE
Int J Cancer; 2008 May; 122(9):1923-30. PubMed ID: 18183577
[TBL] [Abstract][Full Text] [Related]
16. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
Puca R; Nardinocchi L; Pistritto G; D'Orazi G
Gynecol Oncol; 2008 Jun; 109(3):403-10. PubMed ID: 18395248
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-191 modulates cisplatin-induced DNA damage response by targeting RCC2.
Xu X; Zhou X; Zhang J; Li H; Cao Y; Tan X; Zhu X; Yang J
FASEB J; 2020 Oct; 34(10):13573-13585. PubMed ID: 32803782
[TBL] [Abstract][Full Text] [Related]
19. Regulator of Chromosome Condensation 2 Modulates Cell Cycle Progression, Tumorigenesis, and Therapeutic Resistance.
Guo K; Zhao C; Lang B; Wang H; Zheng H; Zhang F
Front Mol Biosci; 2020; 7():620973. PubMed ID: 33521058
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway.
Liu H; Huang J; Peng J; Wu X; Zhang Y; Zhu W; Guo L
Mol Cancer; 2015 Mar; 14():59. PubMed ID: 25880778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]